Brutika 90 Tablet
Marketer
Brawn Laboratories Ltd
Salt Composition
Ticagrelor (90mg)
Overview Brutika 90 Tablet
CardioGuard 90mg tablets are antiplatelet agents, also known as blood thinners. They work by inhibiting the formation of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in individuals with cardiac conditions. CardioGuard 90mg is also indicated for patients recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or post-stent placement. Its use helps prevent future cardiac events such as further heart attacks, strokes, or clot formation within stents. Concomitant use with aspirin, another antiplatelet medication, is typically prescribed. CardioGuard 90mg can be taken with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as discontinuation increases the risk of recurrent cardiac events. The most frequent adverse effect is increased bleeding tendency; injuries may bleed longer than normal, though this is usually mild and self-limiting. Some patients experience mild shortness of breath, which typically subsides with continued therapy. Report persistent bleeding or worsening/unresolved breathlessness to your physician. CardioGuard 90mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcer, cerebral hemorrhage) or liver disease. Disclose any such conditions to your doctor before commencing treatment.
Uses of Brutika 90 Tablet
Reducing the risk of cardiovascular events
Major Benefits of Brutika 90 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Brutika 90 Tablet. The tablet should be swallowed whole; do not chew, crush, or fracture it. While you can take it with or without food, consistency is key—choose a regular time each day.
Common Side effects of Brutika 90 Tablet:
- Bleeding
- Breathlessness
How to use Brutika 90 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brutika 90 Tablet can be consumed with or without food, although consistent timing is recommended.
How Brutika 90 Tablet works:
Brutika 90 Tablets inhibit platelet aggregation, a process crucial in blood clot formation. This antiplatelet action reduces the risk of cardiovascular events such as heart attacks and strokes.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Brutika 90 Tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Brutika 90 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Brutika 90 Tablet with breastfeeding is unavailable. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Brutika 90 Tablet.
KidneySAFE IF PRESCRIBED
Brutika 90 Tablet poses no known safety concerns for individuals with kidney disease and requires no dosage modification. Data regarding Brutika 90 Tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Brutika 90 Tablet cautiously, potentially requiring dosage modification under medical supervision. Brutika 90 Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Brutika 90 Tablet :
Should you forget a Brutika 90 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Brutika 90 Tablet
Label | Value |
---|---|
Chemical Classification | Triazolopyrimidine derivatives |
Developing Habits | No. |
Treatment Category | KINSHIP |
Action Class | ADP receptor antagonists (P2Y12 inhibitors) |